Physician profile
Gregory C Borstad
NPI 1528057056
$907.74
in general payments reported to CMS, 2019-2025
16 companies · $86.55 in 2025
The $86.55 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $75.87 · 2021: $129 · 2022: $24.06 · 2023: $255 · 2024: $122 · 2025: $86.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $192.43 | 2019-2020 | |
| Amgen INC. | $114.44 | 2020-2025 | Otezla, Enbrel, Tavneos |
| Abbvie INC. | $93.80 | 2019-2023 | Rinvoq |
| Janssen Biotech, INC. | $80.03 | 2021-2024 | Tremfya, Simponi Aria, Remicade |
| Novartis Pharmaceuticals Corporation | $65.47 | 2019-2025 | |
| Ucb, INC. | $64.38 | 2021-2023 | Cimzia |
| Fresenius Kabi USA, LLC | $44.20 | 2023-2024 | Idacio |
| Ultragenyx Pharmaceutical INC. | $42.07 | 2021-2022 | |
| Sandoz INC. | $39.94 | 2023-2024 | Hyrimoz |
| E.R. Squibb & Sons, L.L.C. | $33.99 | 2019-2023 | Orencia |
| Lilly USA, LLC | $32.36 | 2023-2024 | Taltz, Olumiant |
| Horizon Therapeutics Plc | $26.70 | 2020 | |
| Radius Health, INC. | $25.85 | 2025 | Tymlos |
| Pfizer INC. | $18.70 | 2023 | |
| Organon LLC | $17.70 | 2023 | Hadlima |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Borstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.